SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the dominant focus, with traders watching guidance, subscriber engagement and advertising growth amid concerns about competition and a prolonged share-price decline. Many expect further weakness, while bulls argue pessimism is already priced in and see room for a rebound if results or the outlook are stronger than feared.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Heavy buying and a sharp rebound have fueled speculation about a potential buyout or imminent company news, but neither has been confirmed. The main catalyst in discussion is the Phase 3 REGAL trials pending final analysis after the last disclosed count of 78 of 80 events; bullish traders read the CEOs optimistic anniversary post as encouraging, while skeptics point to the lack of new trial news and caution that the move may reflect trading activity.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is largely tied to anticipation of the detailed Phase 3 melanoma cancer-vaccine results with Merck at ESMO, after positive topline results sparked a major revaluation. Traders are split between momentum-driven optimism about the broader oncology platform and concerns that expectations and valuation are stretched, with some anticipating a sell-the-news pullback.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp rebound above recent technical levels has traders discussing a possible breakout and short covering, though no specific new catalyst is confirmed. Bulls are also anticipating DM1 and FSHD siRNA readouts, while some caution that the move may reflect broader biotech strength or prove temporary.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is under pressure amid broader concerns about neocloud funding, debt, and whether AI infrastructure spending will generate adequate returns; co-CEO Daniel Roberts comments that the data centers were cash-funded and customer prepayments help cover GPU costs are being cited as reassurance. Traders are split between viewing the selloff as an oversold buying opportunity and expecting further downside, with many frustrated that IREN has lagged peers.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs shares fell despite a third-quarter earnings beat and a new buyback, as traders focused on the narrowed full-year profit outlook and unchanged midpoint. The reaction is split between dip buyers citing cash generation and repurchases, and bears who see the outlook and softer sales as outweighing those positives.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospaces quarterly beat and raised 2026 outlook are being overshadowed by a sharp selloff. Traders debate whether it is a sell-the-news reaction after expectations ran high or a response to rising costs, weaker cash conversion and an insurance loss, while some point to strong orders as evidence demand remains robust.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports RAP-219 Phase 2 trial in bipolar mania met its primary and secondary endpoints, fueling buying interest and analyst optimism. Traders are debating whether the efficacy signal is strong enough given the modest placebo-adjusted improvement, higher discontinuation rates, and safety questions, contributing to volatile trading.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriad Genetics agreement to sell its prenatal testing business to Labcorp has driven the sharp share move, with traders viewing the cash sale as a balance-sheet and strategic reset. The community is split between bullish momentum and concern that divesting a revenue-generating unit could leave the remaining business smaller and debt pressures unresolved.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA is drawing attention as traders watch for Q3 results to confirm continued growth in high-margin ASCENIV amid weakness in BIVIGAM, with the recent move around its 200-day average adding to the recovery discussion. Bulls point to ASCENIV and share repurchases, while skeptics cite uncertain growth and lingering concerns from the Culper short report and related litigation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stocktwits Retail Therapy: Consumer Stocks Snap Losing Streaks As Planet Fitness, MercadoLibre And Genius Sports Rally 

Equity

Consumer ETFs recovered after several weeks of losses, led by gains in Planet Fitness, MercadoLibre and Genius Sports. Meanwhile, weak delivery figures and lower price targets pressured Lucid, Polestar and Levi Strauss. 

PLNT Stock Heads For Best Day In 2026 — UBS Says Agentic AI Threat Is Manageable

UBS maintained its ‘Buy’ rating and $80 price target, implying a 68% upside potential from current levels.

Why Planet Fitness (PLNT) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Planet Fitness COO Dumps 23% of His Direct Equity Stake After the Stock Crashed

Key PointsThe transaction involved the disposal of 7,000 shares at a weighted average price of $51.22 per share, totaling $358,540...

Waste Of The Day: Trips To Tiki Bar, Nightclubs

Waste Of The Day: Trips To Tiki Bar, Nightclubs

 Authored by Jeremy Portnoy via RealClearInvestigations,

It's no wonder that California's infamous high-speed rail line has more than tripled in cost and been delayed by 20 years. The consultants working on the project have been killing...

Citrini's New Short List: 90 Subscription Stocks at Risk From The 'Agentic Cancellation Wave'

Citrini's short list targets 90 subscription stocks, from Planet Fitness to Comcast and Sirius XM, as AI agents cancel and renegotiate.read more...

Insider Buy: Planet Fitness Director Acquires Shares Valued at Nearly $120,000

Key PointsDirector Christopher Tanco acquired 2,328 shares at an execution price of $51.23 per share on September 14, 2026, for a total cost of ~$119,263...

California high-speed rail consultants billed taxpayers for a private plane, tiki bars and cigar lounges

California High-Speed Rail Authority officials rubber-stamped hundreds of thousands of dollars in travel charges incurred by outside consultants, according to a new report from the state's inspector general.The lavish spending revelations come as the $126 billion project has become a national...

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Planet Fitness (PLNT) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Planet Fitness, Inc. ("Planet Fitness or the Company) (NYSE: PLNT) and reminds investors of the September 14, 2026 deadline to seek the role of lead plaintiff in a federal securities class action...

PLNT Investors Have Opportunity to Lead Planet Fitness, Inc. Securities Fraud Lawsuit with SBS Law

Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Planet Fitness, Inc. (Planet Fitness or the Company) (NYSE: PLNT) violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated...

Planet Fitness, Inc. engages in the operation and franchising of fitness centers. It operates through the following segments: Franchise, Corporate-Owned Clubs, and Equipment. The Franchise segment includes operations related to the company's franchising business in the United States, Puerto Rico, Canada, Panama, Mexico, and Australia. The Corporate-Owned Clubs segment consists of operations with respect to all corporate-owned clubs throughout the United States, Canada, and Spain. The Equipment segment involves the sale of equipment to franchisee-owned clubs in the United States, Canada, and Mexico. The company was founded by Michael Grondahl and Marc Grondahl in 1992 and is headquartered in Hampton, NH.

Planet Fitness Inc - Ordinary Shares - Class A

Bearish Sentiment

<ul class="summary-bullets"><li>XLP rose 3.6%, ending a seven-week losing streak, while XLY gained 2.55%, breaking an eight-week slide.&nbsp;</li><li>Planet Fitness climbed13% as UBS said investor sentiment looks “far worse” than fundamentals.&nbsp;</li><li>Lucid delivered 3,806 vehicles in Q3, well below the 5,900 analysts expected.&nbsp;</li></ul>Consumer stocks finally caught a break last week, with both major sector ETFs snapping long losing streaks. Planet Fitness (PLNT), MercadoLibre (MELI) and Genius Sports (GENI) led the advance on analyst support and institutional buying. Polestar Automotive (PSNY), Lucid Group (LCID) and Levi Strauss (LEVI) declined as earnings and delivery reports disappointed.During the week of Oct. 5 to Oct. 9, the<a href="https://stocktwits.com/symbol/XLP">&nbsp;Consumer Staples Select Sector SPDR Fund</a> (XLP) rose 3.6%, reversing seven straight weeks of losses. The<a href="https://stocktwits.com/symbol/XLY">&nbsp;Consumer Discretionary Select Sector SPDR Fund</a> (XLY) gained 2.55%, ending an eight-week skid.Both funds outpaced the broader market. The<a href="https://stocktwits.com/symbol/SPY">&nbsp;SPDR S&amp;P 500 ETF Trust</a> (SPY) advanced 1.16%, while the tech-heavy<a href="https://stocktwits.com/symbol/QQQ">&nbsp;Invesco QQQ Trust</a> (QQQ) edged up 0.23%.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261011_084607435_2ca947ae3c.png" alt="koyfin_20261011_084607435.png" width="2400" height="1240"></figure><h2 class="st-heading-2">Planet Fitness, MercadoLibre, Genius Sports Among Leading Gainers</h2><a href="https://stocktwits.com/symbol/PLNT">Planet Fitness stock</a> rose 13% and posted its best week since May after UBS said investor sentiment looks “far worse” than the company’s fundamentals heading into its third-quarter earnings report. The firm said that against a “deteriorating sentiment backdrop,” the fitness chain’s fundamentals have actually improved. UBS data show strong member growth in September and continued strength in early October.The analyst called the risk from agentic AI “sensible but manageable in practice” and said Planet Fitness’ pricing promotion has been a success. UBS maintained a ‘Buy’ rating and an $80 price target.<a href="https://stocktwits.com/symbol/MELI">MercadoLibre stock</a> rallied over 11% to its best week in over two years as investors reacted to the first round of Brazil’s presidential election. Traders are weighing how potential shifts in regulation and economic conditions could affect the company’s largest market, and positioning ahead of anticipated policy impacts.Susquehanna raised its price target to $2,500 from $2,400 and kept a ‘Positive’ rating. The firm said that although MercadoLibre continues to invest in developing the market for its products and services, changes in its consumer credit book may begin to lift consolidated EBIT margins. Those margins have fallen year-on-year every quarter since 2023.<a href="https://stocktwits.com/symbol/GENI">Genius Sports stock</a> also advanced over 10% during the week as Cathie Wood’s ARK Investment kept buying. The firm picked up 425,800 shares on Oct. 6 and another 347,800 shares on Oct. 8.<h2 class="st-heading-2">Polestar, Lucid, Levi Strauss Decline</h2><a href="https://stocktwits.com/symbol/PSNY">Polestar stock</a> posted a weekly decline of 15% as&nbsp; Barclays cut its price target to $5 from $15 and kept an ‘Underweight’ rating. The cut was part of a Q3 earnings preview for the autos and mobility group. The analyst said macro challenges in 2027 reinforce a preference for U.S. exposure.Lucid Group produced 2,954 vehicles and delivered 3,806 in Q3. Deliveries exceeded production as the company reduced its existing inventory as part of a plan to improve cash flow by $1.4 billion in 2026.&nbsp;The numbers still missed. FactSet estimates stood at 3,497 for production and 5,900 for deliveries. StoneX, which has a ‘Hold’ rating, said the “substantial delivery shortfall underscores the challenge of improving sell-through.” BNP Paribas analyst James Picariello called the report “lackluster” and said Lucid faces a “long and difficult journey” to improve operations and drive demand.&nbsp;<a href="https://stocktwits.com/symbol/LCID">Lucid stock</a> fell over 8% during the week.&nbsp;<a href="https://stocktwits.com/symbol/LEVI">Levi Strauss stock</a> declined nearly 6% last week after the denim maker raised its profit outlook, largely on tariff refunds, but trimmed its revenue guidance. Adjusted full-year EPS is now expected at $1.54 to $1.56, up from $1.46 to $1.52. That’s above the $1.49 analysts expected, according to Fiscal.ai data. Net revenue growth guidance was lowered to 7%, the bottom of the prior 7% to 7.5% range, while organic growth is expected at 6%.In Q3, tariff refunds helped boost Levi Strauss’ operating margin by 4.9 percentage points to 13.8%. U.S. revenue fell 1%, while comparable sales from its own stores and website were nearly unchanged. CEO Michelle Gass said direct sales fell below expectations, and the company has already started taking steps to improve results.&nbsp;Raymond James cut its price target to $22 from $24 but kept an ‘Outperform’ rating, saying course corrections and improved weather point to a better Q4. JPMorgan trimmed its target to $33 from $34 and kept an Overweight rating, calling the report mixed but the multi-year growth outlook intact.&nbsp;Also see:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/khc-clx-hsy-stocks-in-focus-consumer-staples-lag-the-market-but-analyst-sees-potential-in-these-three-names/cZx4y2LRBFL">KHC, CLX, HSY Stocks In Focus: Consumer Staples Lag The Market, But Analyst Sees Potential In These Three Names</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a MercadoLibre, Inc. logo is seen on a smartphone screen.

Consumer stocks finally caught a break last week, with both major sector ETFs snapping long losing streaks. Planet Fitness (PLNT), MercadoLibre (MELI) and Genius Sports (GENI) led the advance on analyst support and institutional buying. Polestar Automotiv

Why Consumer Stocks Rebounded Last Week: Planet Fitness, MercadoLibre And More

Genius Sports Limited

Lucid Group Inc

Levi Strauss & Co. - Ordinary Shares Cls A

MercadoLibre Inc

Polestar Automotive Holding UK PLC

Consumer Staples Select Sector SPDR Fund

Consumer Discretionary Select Sector SPDR Fund

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Current Price	$53.42
Prev Close	$52.89
Open	$53.32
Dividend Yield	0.00%
50-Day Moving Average	$48.39
Beta	0.62
Avg. Volume	2.66M
PE Ratio	17.95

52-Week High	$114.26
52-Week Low	$37.03
Market Capitalization	$3.99B
EPS (Annual)	$2.62
Price to Book	-6.49
Revenue Per Employee	$329,389.05

Feed

News

Sentiment

Earnings

Fundamentals

Info

PLNT Fundamentals